Literature DB >> 24071451

Two α-dicarbonyls downregulate migration, invasion, and adhesion of liver cancer cells in a p53-dependent manner.

Lorena Loarca1, Sihem Sassi-Gaha, Carol M Artlett.   

Abstract

BACKGROUND: Hepatocellular carcinoma accounts for more than 600,000 deaths per year due to it being a highly invasive tumor. The α-dicarbonyl, methylglyoxal demonstrates efficacy at reducing tumor burden, however the anti-cancerous activities of 3-deoxyglucosone, have never been studied. AIMS: To determine the anti-cancerous potential of methylglyoxal and 3-deoxyglucosone on liver tumor cells.
METHODS: The in vitro effects of methylglyoxal and 3-deoxyglucosone were studied by investigating migration, invasion, and adhesion of Huh-7, HepG2, and Hep3B cells.
RESULTS: 3-Deoxyglucosone inhibited migration of Huh-7 and HepG2 cells. Methylglyoxal decreased migration of HepG2 cells. Additionally, 3-deoxyglucosone and methylglyoxal impaired invasion, and adhesion of Huh-7 and HepG2 cells. In Hep3B cells, a p53 null cell line, 3-deoxyglucosone and methylglyoxal had no effect on migration, invasion, or adhesion. However, both compounds inhibited invasion of wild-type p53 transfected Hep3B cells. Silencing of p53 in Huh-7 and HepG2 cells abrogated the effects of the α-dicarbonyls on cell invasion. 3DG and MG did not alter p53 total protein but promoted nuclear translocation of p53.
CONCLUSIONS: These studies suggest that 3-deoxyglucosone and methylglyoxal impair invasion, migration, and adhesion of hepatocellular carcinoma. The effects of both compounds on cell invasion are dependent on p53 and imply that α-dicarbonyls could be efficacious in the treatment of p53-expressing invasive liver tumors.
Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-Deoxyglucosone; Adhesion; Invasion; Methylglyoxal; Migration; p53

Mesh:

Substances:

Year:  2013        PMID: 24071451     DOI: 10.1016/j.dld.2013.05.005

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

1.  Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.

Authors:  Xiao-Yan Zou; Dong Ding; Na Zhan; Xiao-Ming Liu; Cheng Pan; Yu-Min Xia
Journal:  J Invest Dermatol       Date:  2014-09-03       Impact factor: 8.551

Review 2.  Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.

Authors:  Seigmund Wai Tsuen Lai; Edwin De Jesus Lopez Gonzalez; Tala Zoukari; Priscilla Ki; Sarah C Shuck
Journal:  Chem Res Toxicol       Date:  2022-10-05       Impact factor: 3.973

3.  Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.

Authors:  Yi Guo; Yuning Zhang; Xunjun Yang; Panpan Lu; Xijuan Yan; Fanglan Xiao; Huaibin Zhou; Chaowei Wen; Mengru Shi; Jianxin Lu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

4.  Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression.

Authors:  Tiantian He; Huaibin Zhou; Chunmei Li; Yuan Chen; Xiaowan Chen; Chenli Li; Jiating Mao; Jianxin Lyu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2016-07-25       Impact factor: 4.742

5.  Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.

Authors:  Qi-Fei Tao; Sheng-Xian Yuan; Fu Yang; Sen Yang; Yuan Yang; Ji-Hang Yuan; Zhen-Guang Wang; Qing-Guo Xu; Kong-Ying Lin; Jie Cai; Jian Yu; Wei-Long Huang; Xiao-Lei Teng; Chuan-Chuan Zhou; Fang Wang; Shu-Han Sun; Wei-Ping Zhou
Journal:  Mol Cancer       Date:  2015-09-17       Impact factor: 27.401

6.  Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma.

Authors:  Maurice Michel; Marcus Hollenbach; Sabine Pohl; Cristina Ripoll; Alexander Zipprich
Journal:  Front Oncol       Date:  2019-08-20       Impact factor: 6.244

Review 7.  The Dual-Role of Methylglyoxal in Tumor Progression - Novel Therapeutic Approaches.

Authors:  Alessia Leone; Cecilia Nigro; Antonella Nicolò; Immacolata Prevenzano; Pietro Formisano; Francesco Beguinot; Claudia Miele
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

Review 8.  Glyoxalase System in the Progression of Skin Aging and Skin Malignancies.

Authors:  Silvia Yumnam; Lalita Subedi; Sun Yeou Kim
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

9.  Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway.

Authors:  Yuan Chen; Lei Fang; Gefei Li; Jiali Zhang; Changxi Li; Mengni Ma; Chen Guan; Fumao Bai; Jianxin Lyu; Qing H Meng
Journal:  Oncotarget       Date:  2017-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.